Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs Altria Group Inc (MO) Price & Performance

CVS Health CorpTrade
Altria Group IncTrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs Altria Group Inc — how do they compare? CVS Health Corp trades at $106.03 (market cap $135.12B), while Altria Group Inc trades at $70.31 (market cap $120.02B). The key difference: CVS Health Corp and Altria Group Inc are close in size by market cap, and Altria Group Inc pays the higher dividend (5.9%). Which is the better fit depends on your goals.

CVSMO
Market Cap
$135.12B$120.02B
Sector
HealthConsumer Staples
52-Week High
$106.18$74.55
52-Week Low
$58.75$54.72
Enterprise Value
$201.66B$141.09B
Dividend Yield
2.51%5.9%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

Read more on MO